Healthcare and Life Science
AstraZeneca and Northern Ireland Forge New Strategic Partnership Aiming to Transform Healthcare and Boost Innovation
Belfast, UK, April 24, 2026 – AstraZeneca and Northern Ireland Department of Health, the Department for the Economy and the Health Innovation Research Alliance NI (HIRANI) today announced their intent to enter into a first-of-its-kind strategic Memorandum of Understanding (MOU), aimed a...
Summer offer from Hinxton Hall Conference Centre
Whether you're planning for Q4, hosting a team away day, delivering training, or running a workshop, Hinxton Hall offers the ideal setting for productive meetings in beautiful surroundings. ...
Polygenic scores and public health services: moving the debate forward
New report from PHG Foundation is designed to help those making and shaping decisions around when and how polygenic scores could be implemented within publicly funded initiatives and specifically in the English NHS. The report draws on the insights of participants at a recent PHG-conven...
Yu Sun joins Salus Wellness
We are very pleased to announce that Yu Sun has joined Salus Wellness this month. ...
Celtic Renewables appoints Allen Associates as it plans new biorefinery in Grangemouth
Tuesday 25 November 2025 – Celtic Renewables is moving forward with plans to build a new industrial-scale green chemical production plant in Grangemouth. It has appointed engineering design consultancy Allen Associates, part of the Forsyths Group of companies, to undertake extensive wor...
Cambridge Forum announces world-class speaker line-up for AI & Health Conference
Cambridge Forum is delighted to announce a line-up of eminent speakers for its Tech for Good: AI and Health event, taking place on 10th and 11th September at Cambridge Corn Exchange. ...
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
ClearPoint Neuro’s system enables precise delivery to the seizure focus, ensuring best possible efficacy and safety of EpilepsyGTx’s investigational gene therapyPartnership will support first-in-human Phase 1/2a clinical trials of EPY201 in patients with focal refractory epilepsy L...
DDW introduces new series of events aimed at connecting innovation with investment in early-stage drug discovery
Three-part event series will comprise a digital forum (30th September 2026), and two in-person events (London, UK, 4th November 2026, and Basel, Switzerland, March 2027)Focused on technology, innovation, and investment in early-stage drug discovery, the events will bring together senior...
Camena Bioscience appoints Gregory P. McGuinness as CEO
Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic growth plans, including commercialisation of the gSynth® platform for AI-driven antibody discovery, and operational scalingCa...
Novogene Europe launches Untargeted Metabolomics Service at Cambridge Omics Centre
• Strengthens multiomics portfolio offering metabolite-level insight to connect molecular data with biological function across broader life science studies • New workflow built around Thermo Scientific Vanquish UHPLC coupled with Orbitrap Exploris 120 high-resolution accurate-mass mass ...